29th Meeting of the EAU Section of Urological Research (ESUR)

Tradeshow/Conference
Basel, Switzerland

Event Overview

This meeting on experimental urological research will count with outstanding international experts presenting their latest basic and translational findings. In particular, the newer generation of model systems (e.g. patient-derived organoids, xenografts, mouse models) and their application to decipher mechanisms driving urological diseases and treatment resistance, as well as their use for precision medicine. In addition, it will tackle hot topics in the field of urological research which include (i) combination therapies (ii) infectiology, immunity, and microbiome, (iii) spatial biology, and (iv) extracellular vesicles: from mechanisms to therapeutic opportunities.

Visit us at Booth #1

To schedule a meeting with our team during the ESUR 2023, please contact Irene Yujnovsky at iyujnovsky@nanostring.com.

NanoString Workshop | Discover what’s new in spatial biology | October 19th | 11:30-13:00 CEST | Room 01.004

The NanoString symposium will showcase our innovative discovery and translational research spatial solutions and how they are applied in the field of urology.

  • Mathias Holpert will introduce how our platforms allow researchers to combine whole tissue imaging, gene expression, and protein data. See how you can achieve multicellular analysis with GeoMx® Digital Spatial Profiler, or zoom in to view single cells with the CosMx™ Spatial Molecular Imager (SMI). Join us to discover how AtoMx™ Spatial Informatics Platform (SIP) facilitates spatial biology analysis anytime, anywhere thanks to its advanced data analytics and global collaboration capabilities.
  • Andre Oszwald will share their latest results on upper tract urothelial carcinoma, on prostate cancer as well as human and murine glomerulonephritis using the GeoMx® Digital Spatial Profiler during his presentation entitled ‘Spatial profiling in the urogenital tract: a user perspective’.

The CosMx™ SMI and decoder probes are not offered and/or delivered to the Federal Republic of Germany for use in the Federal Republic of Germany for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof in a method used in fluorescence in situ hybridization for detecting a plurality of analytes in a sample without the consent of the President and Fellows of Harvard College (Harvard Corporation) as owner of the German part of EP 2 794 928 B1. The use for the detection of cellular RNA, messenger RNA, microRNA, ribosomal RNA and any combinations thereof is prohibited without the consent of the President and Fellows of Harvard College (Harvard Corporation).

The CosMx™ SMI and decoder probes are not offered and/or delivered to the following UPC member states* for use in these countries for the detection of RNA in a method used for the detection of a plurality of analytes in a cell or tissue sample without the consent of the President and Fellows of Harvard College (Harvard Corporation) as owner of the Unitary Patent EP 4 108 782 B1. The use for the detection of RNA is prohibited without the consent of the President and Fellows of Harvard College (Harvard Corporation).

* Austria, Belgium, Bulgaria, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Portugal, Slovenia, Sweden

Speakers

Mathias Holpert, PhD

Principal Product Application Scientist, NanoString Technologies

Andre Oszwald, MD

Department of Pathology, Medical University of Vienna